Lin et al. showed that PLK1 inhibition significantly prevented liver tumorigenesis in transgenic mice, primary cells, and HCC [56], proposing a new strategy for ubiquitinylase-PLK1-targeted treatment of hepatocellular carcinoma. Here, PLK1 is linked to hepatocellular carcinoma.